Table 1. Patients’ characteristics and efficacy essessments.
Pat No | Sex | Age | M- Comp Class | Diagnosis SMM yr. before inclusion | Serum M protein at diagnosis g/100 ml | Serum M protein Day 1 g/100 ml | Serum M protein Day 50 g/100 ml | Urinary M protein at screening mg/24 h | Urinary M protein Day 50 mg/24 h | BMPCs (%) at screening | BMPCs (%) Day 50 resp. Day 69 |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 66 | A kappa | 2.8 | 1.9 | 1.8 | 1.9 | 78 | 62 | 8 | 12 |
2 | M | 64 | G kappa | 2.3 | 0.7 | 0.9 | 0.9 | 497 | 664 | 17 | 9 |
3 | M | 67 | G lambda | 2.5 | 2.8 | 3.0 | 3.6 | 18 | 0 | 11 | |
4 | F | 50 | G kappa | 8.4 | 2.0 | 2.2 | 11 |